Detection of lung cancer relapse using self-reported symptoms transmitted via an Internet Web-application: pilot study of the sentinel follow-up

被引:52
作者
Denis, Fabrice [1 ,2 ]
Viger, Louise [2 ]
Charron, Alexandre [1 ]
Voog, Eric [1 ]
Dupuis, Olivier [1 ]
Pointreau, Yoann [1 ]
Letellier, Christophe [2 ]
机构
[1] Private Inst Canc, Le Mans, France
[2] CORIA Univ Rouen, F-76801 Saint Etienne Du Rouvray, France
关键词
Lung cancer; Follow-up; Supportive care; Personalized medicine; Early relapse detection; M-health; CHEMOTHERAPY; OUTCOMES; TOXICITIES;
D O I
10.1007/s00520-013-2111-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to investigate whether patient self-evaluated symptoms transmitted via Internet can be used between planned visits to provide an early indication of disease relapse in lung cancer. Between 2/2013 and 8/2013, 42 patients with lung cancer having access to Internet were prospectively recruited to weekly fill a form of 11 self-assessed symptoms called "sentinel follow-up". Data were sent to the oncologist in real-time between planned visits. An alert email was sent to oncologist when self-scored symptoms matched some predefined criteria. Follow-up visit and imaging were then organized after a phone call for confirming suspect symptoms. Weekly and monthly compliances, easiness with which patients used the web-application and the accuracy of the sentinel follow-up for relapse detection were assessed and compared to a routine visit and imaging follow-up. Median follow-up duration was 18 weeks (8-32). Weekly and monthly average compliances were 79 and 94 %, respectively. Sixty percents of patients declared to be less anxious during the few days before planned visit and imaging with the sentinel follow-up than without. Sensitivity, specificity, positive, and negative predictive values provided by the sentinel (planned imaging) follow-up were 100 %(84 %), 89 %(96 %), 81 %(91 %), and 100 %(93 %), respectively and well correlated with relapse (p chi (2) < 0.001). On average, relapses were detectable 5 weeks earlier with sentinel than planned visit. An individualized cancer follow-up that schedule visit and imaging according to the patient status based on weekly self-reported symptoms transmitted via Internet is feasible with high compliance. It may even provide earlier detection of lung cancer relapse and care.
引用
收藏
页码:1467 / 1473
页数:7
相关论文
共 14 条
[1]  
[Anonymous], 2012, NCCN GUID VERS 1 NON
[2]   Patient online self-reporting of toxicity symptoms during chemotherapy [J].
Basch, E ;
Artz, D ;
Dulko, D ;
Scher, K ;
Sabbatini, P ;
Hensley, M ;
Mitra, N ;
Speakman, J ;
McCabe, M ;
Schrag, D .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3552-3561
[3]   Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy [J].
Basch, Ethan ;
Iasonos, Alexia ;
Barz, Allison ;
Culkin, Ann ;
Kris, Mark G. ;
Artz, David ;
Fearn, Paul ;
Speakman, John ;
Farquhar, Rena ;
Scher, Howard I. ;
McCabe, Mary ;
Schrag, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5374-5380
[4]  
Denis F, 2013, SUPPORT CARE CANC
[5]   Who should follow up lung cancer patients after operation? [J].
Gilbert, S ;
Reid, KR ;
Lam, MY ;
Petsikas, D .
ANNALS OF THORACIC SURGERY, 2000, 69 (06) :1696-1700
[6]   Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy [J].
Judson, Timothy J. ;
Bennett, Antonia V. ;
Rogak, Lauren J. ;
Sit, Laura ;
Barz, Allison ;
Kris, Mark G. ;
Hudis, Clifford A. ;
Scher, Howard I. ;
Sabattini, Paul ;
Schrag, Deborah ;
Basch, Ethan .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) :2580-+
[7]   Symptoms, psychological distress, and supportive care needs in lung cancer patients [J].
Liao, Yu-Chien ;
Liao, Wei-Yu ;
Shun, Shiow-Ching ;
Yu, Chong-Jen ;
Yang, Pan-Chyr ;
Lai, Yeur-Hur .
SUPPORTIVE CARE IN CANCER, 2011, 19 (11) :1743-1751
[8]   Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study [J].
Narducci, Filomena ;
Grande, Roberta ;
Mentuccia, Lucia ;
Trapasso, Tiziana ;
Sperduti, Isabella ;
Magnolfi, Emanuela ;
Fariello, Anna Maria ;
Gemma, Donatello ;
Gamucci, Teresa .
SUPPORTIVE CARE IN CANCER, 2012, 20 (06) :1221-1226
[9]   American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003 [J].
Pfister, DG ;
Johnson, DH ;
Azzoli, CG ;
Sause, W ;
Smith, TJ ;
Baker, S ;
Olak, J ;
Stover, D ;
Strawn, JR ;
Turrisi, AT ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :330-353
[10]   Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase II Clinical Trial [J].
Pietanza, M. Catherine ;
Basch, Ethan M. ;
Lash, Alex ;
Schwartz, Lawrence H. ;
Ginsberg, Michelle S. ;
Zhao, Binsheng ;
Shouery, Marwan ;
Shaw, Mary ;
Rogak, Lauren J. ;
Wilson, Manda ;
Gabow, Aaron ;
Latif, Marcia ;
Lin, Kai-Hsiung ;
Wu, Qinfei ;
Kass, Samantha L. ;
Miller, Claire P. ;
Tyson, Leslie ;
Sumner, Dyana K. ;
Berkowitz-Hergianto, Alison ;
Sima, Camelia S. ;
Kris, Mark G. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :2004-2009